Central Nervous System Pharmacology — Flashcards

Management of _____ in Parkinson's treatment includes use of COMT inhibitors or irreversible and reversible MAO-B inhibitors to prolong the ON phase

Neuro/Psych _____ is a non-ergot D2 receptor agonist that is used in initial treatment of Parkinson disease

_____, nalorphine, and nalbuphine are κ (kappa)-opioid receptor agonists and weak μ (mu)-opioid receptor antagonists or partial agonists.

_____ is a histamine H3-receptor antagonist/inverse agonist indicated for the treatment of narcolepsy with or without cataplexy.

Effect of acute ethanol is inhibitory on _____ receptor channels and voltage-gated Ca2+ channels

Neuro/Psych _____ is a non-ergot D3 receptor agonist that is used in initial treatment of Parkinson disease

Phencyclidine (PCP) is a hallucinogen that works primarily as an _____ receptor antagonist

Huntington disease may be treated with _____ or reserpine, which inhibit VMAT, decreasing dopamine vesicle packaging and release

Calcium channel blockers, such as _____, may be used for migraine prophylaxis

Cocaine exerts its effects via inhibition of the _____ and DAT transporters (reuptake inhibitor)